Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia-Reference-Cited by-同舟云学术

Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia

Published:2016-04-25 Issue:23 Volume:7 Page:33960-33982
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Perez Dominique R.¹²³,Smagley Yelena¹²,Garcia Matthew¹²,Carter Mark B.¹²,Evangelisti Annette¹²³,Matlawska-Wasowska Ksenia¹⁴,Winter Stuart S.¹⁴,Sklar Larry A.¹²³,Chigaev Alexandre¹²³

Affiliation:

1. University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA

2. University of New Mexico Center for Molecular Discovery, Albuquerque, NM, USA

3. Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA

4. Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapeutic and Antiproliferative Effect of Purified Protein from Marine Catfish Tachysurus Dussumieri on Human Colon Cancer Cell Line;Cell Biochemistry and Biophysics;2024-01-06

2. Development in Drug Repurposing for the Treatment of Acute Leukemia Complicating Metastatic Breast Cancer;Drug and Therapy Development for Triple Negative Breast Cancer;2023-06-16

3. Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991;Medicina;2022-05-24

4. Drug Repositioning for the Treatment of Hematologic Disease: Limits, Challenges and Future Perspectives;Current Medicinal Chemistry;2021-04-29

5. Study of Endogen Substrates, Drug Substrates and Inhibitors Binding Conformations on MRP4 and Its Variants by Molecular Docking and Molecular Dynamics;Molecules;2021-02-17